These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65. Brain mitochondrial function in a murine model of cerebral malaria and the therapeutic effects of rhEPO. Karlsson M; Hempel C; Sjövall F; Hansson MJ; Kurtzhals JA; Elmér E Int J Biochem Cell Biol; 2013 Jan; 45(1):151-5. PubMed ID: 22903021 [TBL] [Abstract][Full Text] [Related]
66. The HFE genotype and a formulated diet controlling for iron status attenuate experimental cerebral malaria in mice. Leitner DF; Stoute JA; Landmesser M; Neely E; Connor JR Int J Parasitol; 2015 Oct; 45(12):797-808. PubMed ID: 26296689 [TBL] [Abstract][Full Text] [Related]
68. Topographical distribution of the cerebral lesions in mice infected with Plasmodium berghei. Polder T; Jerusalem C; Eling W Tropenmed Parasitol; 1983 Dec; 34(4):235-43. PubMed ID: 6364514 [TBL] [Abstract][Full Text] [Related]
69. Nanocurcumin is superior to native curcumin in preventing degenerative changes in Experimental Cerebral Malaria. Dende C; Meena J; Nagarajan P; Nagaraj VA; Panda AK; Padmanaban G Sci Rep; 2017 Aug; 7(1):10062. PubMed ID: 28855623 [TBL] [Abstract][Full Text] [Related]
70. Fluorescein angiography findings strengthen the theoretical basis for trialling neuroprotective agents in cerebral malaria. Maude RJ; Beare NA Trends Parasitol; 2009 Aug; 25(8):350-1. PubMed ID: 19635680 [No Abstract] [Full Text] [Related]
71. Monoclonal antibody against interferon gamma can prevent experimental cerebral malaria and its associated overproduction of tumor necrosis factor. Grau GE; Heremans H; Piguet PF; Pointaire P; Lambert PH; Billiau A; Vassalli P Proc Natl Acad Sci U S A; 1989 Jul; 86(14):5572-4. PubMed ID: 2501793 [TBL] [Abstract][Full Text] [Related]
72. Erythropoietin protects against murine cerebral malaria through actions on host cellular immunity. Wei X; Li Y; Sun X; Zhu X; Feng Y; Liu J; Jiang Y; Shang H; Cui L; Cao Y Infect Immun; 2014 Jan; 82(1):165-73. PubMed ID: 24126529 [TBL] [Abstract][Full Text] [Related]
73. Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria. Grau GE; Fajardo LF; Piguet PF; Allet B; Lambert PH; Vassalli P Science; 1987 Sep; 237(4819):1210-2. PubMed ID: 3306918 [TBL] [Abstract][Full Text] [Related]
74. [Protective effects of artesunate combination on experimental cerebral malaria and nerve injury]. Jiang XH; Chen LN; Li K; Guo Y; Zheng ZY; Yang T; Zheng XJ; Li YJ; Zhu XX Zhongguo Zhong Yao Za Zhi; 2018 Aug; 43(15):3051-3057. PubMed ID: 30200698 [TBL] [Abstract][Full Text] [Related]
75. Anti-erythropoietin antibody levels and its association with anaemia in different strains of semi-immune mice infected with Plasmodium berghei ANKA. Helegbe GK; Huy NT; Yanagi T; Shuaibu MN; Kikuchi M; Cherif MS; Hirayama K Malar J; 2013 Aug; 12():296. PubMed ID: 23978045 [TBL] [Abstract][Full Text] [Related]
76. Nitric oxide in murine malaria: divergent roles in blood and brain suggested by voltametric measures. Buguet A; Vincendeau P; Bouteille B; Burlet S; Cespuglio R Trans R Soc Trop Med Hyg; 1999; 93(6):663-4. PubMed ID: 10717761 [No Abstract] [Full Text] [Related]
77. Erythropoietin Levels Increase during Cerebral Malaria and Correlate with Heme, Interleukin-10 and Tumor Necrosis Factor-Alpha in India. Dalko E; Tchitchek N; Pays L; Herbert F; Cazenave PA; Ravindran B; Sharma S; Nataf S; Das B; Pied S PLoS One; 2016; 11(7):e0158420. PubMed ID: 27441662 [TBL] [Abstract][Full Text] [Related]
78. Intranasal erythropoietin therapy in nervous system disorders. Genc S; Zadeoglulari Z; Oner MG; Genc K; Digicaylioglu M Expert Opin Drug Deliv; 2011 Jan; 8(1):19-32. PubMed ID: 21143002 [TBL] [Abstract][Full Text] [Related]
79. Recombinant erythropoietin as a neuroprotective treatment: in vitro and in vivo models. Juul S Clin Perinatol; 2004 Mar; 31(1):129-42. PubMed ID: 15183662 [TBL] [Abstract][Full Text] [Related]
80. Low dosages of interleukin 1 protect mice against lethal cerebral malaria. Curfs JH; van der Meer JW; Sauerwein RW; Eling WM J Exp Med; 1990 Nov; 172(5):1287-91. PubMed ID: 2230643 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]